Late-breaking results of the COORDINATE-Diabetes trial were presented today at the American Diabetes Association (ADA) 83rd Scientific Sessions in San Diego, California. New research shows that a ...
Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...
iRhythm Technologies reports high prevalence of cardiac arrhythmias in type 2 diabetes patients associated with chronic kidney disease, highlighting early detection importance. iRhythm Technologies, ...
SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback